GC4419 is a normal tissue radioprotector that also enhances the anti-tumor effects of high dose per fraction radiation and immune therapy
by
DrAnthony J. Davis
(Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA), DrMichael Dean Story
(Radiation Oncology, Graduate School of Medical Sciences, UT Southwestern Dallas, USA)
→
Europe/Berlin
Lecture hall, Theory SB3 3.170a (GSI Helmholtzzentrum für Schwerionenforschung GmbH)
Lecture hall, Theory SB3 3.170a
GSI Helmholtzzentrum für Schwerionenforschung GmbH